- Home
- FOLD vs KNTK Comparison
FOLD vs KNTK Comparison
Compare FOLD & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- KNTK
- Stock Information
- Founded
- FOLD 2002
- KNTK 2017
- Country
- FOLD United States
- KNTK United States
- Employees
- FOLD N/A
- KNTK N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- KNTK Natural Gas Distribution
- Sector
- FOLD Health Care
- KNTK Utilities
- Exchange
- FOLD Nasdaq
- KNTK Nasdaq
- Market Cap
- FOLD 2.9B
- KNTK 2.6B
- IPO Year
- FOLD 2007
- KNTK N/A
- Fundamental
- Price
- FOLD $6.08
- KNTK $42.34
- Analyst Decision
- FOLD Buy
- KNTK Buy
- Analyst Count
- FOLD 10
- KNTK 10
- Target Price
- FOLD $16.22
- KNTK $57.50
- AVG Volume (30 Days)
- FOLD 4.6M
- KNTK 884.6K
- Earning Date
- FOLD 05-01-2025
- KNTK 05-07-2025
- Dividend Yield
- FOLD N/A
- KNTK 7.36%
- EPS Growth
- FOLD N/A
- KNTK N/A
- EPS
- FOLD N/A
- KNTK 0.93
- Revenue
- FOLD $543,141,000.00
- KNTK $1,584,798,000.00
- Revenue This Year
- FOLD $21.87
- KNTK $31.70
- Revenue Next Year
- FOLD $22.19
- KNTK $20.53
- P/E Ratio
- FOLD N/A
- KNTK $45.51
- Revenue Growth
- FOLD 28.25
- KNTK 20.36
- 52 Week Low
- FOLD $6.20
- KNTK $37.65
- 52 Week High
- FOLD $12.65
- KNTK $67.60
- Technical
- Relative Strength Index (RSI)
- FOLD 29.58
- KNTK 43.83
- Support Level
- FOLD $6.63
- KNTK $39.33
- Resistance Level
- FOLD $7.71
- KNTK $42.22
- Average True Range (ATR)
- FOLD 0.30
- KNTK 1.43
- MACD
- FOLD -0.05
- KNTK 0.32
- Stochastic Oscillator
- FOLD 13.76
- KNTK 69.24
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About KNTK Kinetik Holdings Inc.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.